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Leukaemogenesis in Down's Syndrome
G. S. GERICKE, P. B. HESSELING, S. BRINK, W. B. BECKER
SUMMARY
Due to the fixed karyotype and documented malignancy
risk in patients with Down's syndrome, recently described
aetiological factors can be assigned to their proper places
in a conceptual framework for leukaemogenesis in these
individuals. This is a more profitable approach than
those in which various types of karyotypic patterns are
matched to different malignancies. It seems that viruses
may play a special role, but they need interaction with
other factors, most of which are present in Down's
syndrome. A unifying concept which may be helpful in
establishing research priorities is presented.
S. Afr. med. l., 51, 158 (1977).
Much has been recorded about chromosomal abnormali-
ties as a cause or consequence of malignant transformation,
and about the correlation of tnmours with specific karyo-
typic patterns.
Special circumstances associated with Down's syndrome
allow a different approach to the problem. In Down's
syndrome a fixed karyotype is found and the increased
risk of different types of malignant change has been
documented...·14 The various possible aetiological factors
can be assembled in a unified concept to form a working
hypothesis of leukaemogenesis in these individuals. The
purpose of tills review is to discuss recent clinical and
experimental findings and to present such a unifying con-
cept for leukaemogenesis in Down's syndrome.
GENERAL FACTORS IN VIRAL
ONCOGENESIS
Although evidence for a viral aetiology for human leukae-
mia has accumulated, it seems highly unlikely that leukae-
mia is contagious in the usual sense of the term. It appears
that tumour initiation may result from a complex inter-
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action of 3 conditions: Ca) genetic predisposition to cancer;
Cb) infection by a tumour virus, especially in irnmuno-
deficient individuals; and Cc) environmental factors.'" (The
first 2 conditions have definitely been proved in mice, where
infection causes leukaemia or immunisation. Susceptible
mice can then be inoculated against leukaemia.) All of
these 3 conditions may be evident in Down's syndrome.
Genetic Predisposition
Krivit and Good" first reported the aSSOCIatIOn between
Down's syndrome and leukaemia in 1957. Holland et al."
followed 2033 probands with Down's syndrome for periods
ranging from 1 to 14 years. During this period 7 index
patients died of leukaemia and 7 from other forms of
cancer. The death rate for leukaemia was 18 times greater
in those with Down's syndrome than in the general popu-
lation, while the mortality from other types of cancer was
2,6 times above the national rate for the USA. The several
studies which support the association between Down's
syndrome and leukaemia have recently been reviewed by
Rosner and Lee:' Acute myelofibrosis may also occur
with unusual frequency in patients with Down's syndrome."
Tumour Viruses
There is evidence that leukaemic children who have
received whole-body irradiation and bone marrow from
their siblings develop leukaemia of donor cell type."
The oncornaviruses represent the leukaemogenic R A
viruses. Human cells can be infected with these viruses and
can be transformed by viral gene products obtained from
animal cells.'"
A type cR A virus was recently isolated from cultured
cells of a patient with myeloblastic leukaemia, but who
did not have Down's syndrome.'"
The evidence of oncogenic viral infections in humans is
important. in view of accumulating evidence that antiviral
immunodeficiency occurs in individuals with Down's
syndrome.··"·35,... It is probably significant that the trisomic
chromosome in persons with Down's syndrome also carries
the locus for interferon-induced antiviral activity." The
existence of 2 types of individuals with Down's syndrome
with lesser and greater degrees of cellular immunodeficiency
has been reported. lO.... The latter type may be more likely
to become chronic hepatitis B surface antigen CHBsAg)
carriers. HBsAg is also f.ound in excess in patients with
lymphocytic leukaemia.' It has not yet been shown that
HBsAg carrier status indicates an immune deficit which
could be implicated in leukaemia, but the significance of
HBsAg carrier status in Down's syndrome must be fully
investigated.
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Environmental Factors
In viral leukaemogenesis in animals. venical transmission
of infection has led to the oncogene hypothesis. which state
that transmission via the zygote results in a viral or pro-
viral genome being present in a repressed state in every
somatic cell.'· Malignancy can result when de-repres ion is
induced by environmental influences such as irradiation.
chemical carcinogens and ageing. Vertical transmission ha
not been conclusively demonstrated in humans. but is ug-
gested by reports uch as a recent epidemiological investi-
gation carried out in California.' which revealed a possible
leukaemia risk to 0 - 4-year-olds due to their mothers having
uffered an influenza infection during the first trimester of
pregnancy. In this case. the virus may also have exened
its oncogenic effect through increased chromosome break-
age. This aspect will be dealt with funher on.
ASSOClATIO BETWEEN DOWN'S
SYNDROME AND LEUKAEMIA
ince the 1890s chromosomal and mitotic irregularities have
been recognised as the one common feature in cancer. This
fact stimulated the mutation theory of cancer at an early
date.'" In 1947. the higher incidpnce of leukaemia in rela-
tives of leukaemia patients led to the consideration of
genetic leukaemogenic factors. 53 In the early sixties. the
chromosome which is present in triplicate in cells of
patients with Down's syndrome was thought to be the same
one which exhibits a long-arm deletion in chronic myeloid
leukaemia (Philadelphia chromosome). Since the leucocyte
alkaline phosphatase level is generally increased in patients
with Down's syndrome and decreased in patients with
chronic myeloid leukaemia. this was thought to prove the
existence of a leucopoiesis locus on this chromosome.
In 1971. O'Riordan et al." showed the Philadelphia
chromosome to be a deleted TO. 22. The extra chromo-
ome in Down's syndrome shows delayed uptake of radio-
isotopes. is more often atellited and shows more intense
staining in its long arms when examined by means of
fluorescence techniques. and thus represents a different G-
group autosome - TO. 21." In spite of the fact that the
association between chromosome 21 and leukaemia has
not been explained in its initial hypothesis. recent findings
emphasise the possibility that chromosome 21 is important
in the onset of the leukaemic process..·.. or is concerned
with abnormal haematopoiesis."'·...,·" The association be-
tween Down's syndrome and leukaemia does not seem to
be a direct cause-effect relationship. but involves an inter-
action between many factors.
VIRUSES, CHROMOSOME BREAKAGE AND
VIRAL GE OME INCORPORATIO
Evidence of a viral aetiology in human leukaemia was
recently provided by Gallagher and Gallo,'" who isolated a
type of cR A virus from cultured blood cells of a patient
with acute myelocytic leukaemia. Since the investigators
had only used biological materials of human origin. con-
tamination with animal viruses was unlikely. Immunologi-
al evidence in this case also indicates that the virus was of
human origin. The major protein were identical to pro-
tein previou Iy isolated from other patients with acute
myelocytic leukaemia.
Proteins from the new viru were immunologicall~
clo ely related to proteins in two viru es that cause leukae-
mia in subhuman primates. but were more distantly related
to proteins from a mouse leukaemia viru . The author
postulate that interaction with other factors may be re-
quired to produce myelogenous leukaemia in man.
Hypothese concerning the infectious transmission of
leukaemia have been tested. but the findings were mostly
negative. Statistical studies of leukaemic clustering have not
provided solid evidence for an :nfectious mode of pread.
The incidence of leukaemia among marital partners of
leukaemic persons or in children born of women with
leukaemia during pregnancy is not exce sive."" These obser-
vations do not exclude the possibility of a viral aetiology
for leukaemia. but may be due to the complex interplay
of many factors.
Chromosome Breakage
The importance of genetic factors in some cases i illu-
trated by the pedigree reported by Zuelzer et al.'" The e
investigators did chromosomal studies of relatives of an
infant with myeloblastic leukaemia and with cytogenetic
features of partial D trisomy. ;:-hey showed excessive
breakage, chromatid exchange, endoreduplication and frag-
ment formation in 3 generations of the affected child's
family. This suggested a genetic factor acting in the manner
of a breakage gene and constituted a possible link between
leukaemogenesis. congenital anomalies and chromosome
aberrations. In this special situation the breakage gene
'... could have facilitated the occurrence of exogenou
mutagenic events. e.g. the entry of hypothetical leukaemia
viruses into the genome of rapidly replicating cells such
a that of bone marrow'. Very little is known about norm
of chromosome breakage in the 'average' population.
Breakage is the phenomenon which occurs before an al:>-
normal chromosome forms. and at least one of these. a
centric fusion of the D-D type. is believed to be one of the
commonest forms of autosomal heterozygosity found in
the population at large." These individuals are believed to
be completely normal. Patients with genetic conditions in
which there is a clearly recognisable increa e in chromo-
some breakage. such as Bloom's syndrome. Fanconi's
anaemia and ataxia telangiectasia. have a notable su cepti-
bility to cancer. especially of the Iymphoreticular system.
Chronic myeloid leukaemia is known to be associated with
a specific type of breakage chromosome. the Philadelphia
chromo ome.
Viruses have been demonstrated to cause at least 3 type
of chromosome breakage in \·itro'· Chromosome breakage
and breaking agents are important, but complex phenomena
and the relationship between breakage and abnormal growth
are very difficult to define. Evidence for increased breakage
in Down's syndrome has been provided by Higurashi
et al.'" who found that cultured cells from patients with
Down' syndrome display more chromosome breakage
after virus infection than those of normal ubjects. We
have found'" nuclear membrane abnormalities in 30 patients
with Down s syndrome. Membrane abnormalities may be
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an underlying factor in the increa ed chromo ome break-
age. ince chromo ome replication i a membran -a 0-
iated phenomenon.
A relationship between experimental immunodeficiency and
D A virus-induced tumours was first reported by
Vandeputte et al.'" Allison et at.' induced tumour by
adenovirus in susceptible mi e after using antilymphocyte
serum or neonatal thymectomy to produce immunodefi-
Hypothetical incorporation of the viru genome into the
hromosome. nucleus or cytoplasm of the ho t cell is the
econd major area of importance.'· Early maternal virus
infection may cause non-disjunction. This mayor may
not be the same viru that is subsequently incorporated
into the genome of the host cell. on-disjunction ma\'
occur through persistence of the nucleolus during meiosis.
or by an effect of the ovum on the nucleol s. leading to a
failure of separation of half bivalents during meiosis.'"
Clinical and laboratory evidence for this concept in-
cludes the following: Collmann and Stoller" have shown
that a cyclical incidence of infective hepatitis was followed
9 months later by the same cyclical pattern in the incidence
of the birth of children with Down's syndrome. Recent
investigations have shown that the nucleoli in man are
organised on the hort arms of the acrocentric chromo-
ome in groups D and G. and this may account for the
apparent non-random involvement of these autosomes in
trisomy, primarily by means of 'nucleolus dysfunction'. If
the trisomy in Down' yndrome is a consequence of the
mechanical prevention of disjunction due to nucleolar per-
sistence, then this immediately suggests a possible reason
why virus infection could be important in relation to the
aetiology of this condition. particularly if the viruses are
D A viruses that replicate within the host cell nu leus.
The nucleolus is assumed to play an important part in the
development of the viru . Polani et at." have suggested in
1960 that the persistence of nuclear remnants might be an
important factor in the development of Down's syndrome.
Factors that are responsible for the dissolution of the
nucleolu at mitosis or meiosis are not well understood.
Tt ha been shown that nucleoli can be made to persist
at mitosis by the use of cobalt salts and that their pro-
pensity for fusion in interphase can be enhanced by
treatment with thyroxin.
Heneen and ichols" have shown that virus infe tion
can increase persisting nucleoli during mitosis in culture.
This holds chromatin together and impedes separation
during anaphase. which can lead to non-disjunction and
tri omy. Bjonness et al.' have described a neonate \ ith
congenital leukaemia and a G trisomy without phenotypic
manifestations of Down's syndrome. These authors postu-
lated that the extra chromosome was of postzygotic origin
due to non-di junction or selective endoreduplication and
that a mutagenic factor such as a virus could have been
important in the initiation of both conditions.
ciency. McEndy ('£ al.' demon trated that thymectomy
often results in a decrea e of mouse leukaemogenesis. Other
works suggest that inta t immunological defences are im-
portant to control R A virus-induced leukaemias and lym-
phomas in the mouse.""""
Immunodeficiency has been studied extensively in graft-
versus-host (GVH) reactions in animal. Recent experi-
ments have demonstrated that the development of GVH-
induced lymphomas is associated with murine leukaemia
virus activation.'· In mixed leucocyte culture systems, blast
formation is often associated with leukaemia virus activa-
tion."
A finding which may be important in understanding
the relationship between virus immunity and cancer risk.
is the localisation by abholz'" and by Tan e£ al.'" of the
interferon-induced antiviral locus on chromosome 21. Tan
e£ a'."' illustrated a gene dosage effect for this locus by
demonstrating an enhanced antiviral response in trisomy 21
fibroblasts in \'i,ro as compared with trisomy 13, trisomy
18 and diploid control fibroblasts. It is possibly significant
that the gene which regulates the expression of the anti-
viral state is situated on the ame chromosome which is
associated with a high leukaemic risk in the trisomic state.
It is not clear how the observations of enhanced antiviral
response in cultured cell with trisomy 21 can be related to
findings which indicate abnormal virus immunity in Down'
syndrome. Knowledge of the effect of regulator genes on
separate chromosomes and of the factors which could
influence these regulator genes would be important in thi
context.
Evidence of disturbed virus immunity in Down's syn-
drome includes increased susceptibiLity to ill \'itro trans-
formation after exposure to oncogenic SV40 virus." It i
interesting that monosomy of G-group chromosomes in
primary human cells transformed by SV-W virus has been
reported by Shein and Ender" in an early study. Possibly
the gene responsible for antiviral activity could exhibit
less functional activity in monosomy than when it dis-
plays a gene dosage effect in trisomy. We have shown that
46°~ of reported patient with the 11 deletion syndrome
suffered from repeated infections." Yamada and Furusawa"
have found an unusually high figure of involvement of
the No. 21 chromosome in 8 patients with leukaemia; In
5 of these. monosomy for No. 21 was present.
Other important findings are the depressed reactivity to-
skin test antigens in \·i\·o." impaired PHA response." and
viral-like inclusions found in the blasts of a patient with
Down's syndrome and leukaemia.' Such a virus may be
of aetiological importance or it may simply represent a
passenger unrelated to the leukaemic process. Levin eT al."
substantiated previous reports of a deficient T-cell system
in individuals with Down's syndrome. They found the T-
cell population in children with Down's syndrome to be
only 60o~ of that in normal children. The infections seen
were not of the type usually found in children with grossly
deficient T-cell systems af)d thymic aplasia. such as moni-
liasis or progressive vaccinia. but rather the common
bacterial and viral respiratory infections. In individuals
with Down's yndrome who develop leukaemia it may be
that transformation frequency of target cells i of uch
magnitude that other immunological surveillance mecha-
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unifying concept from the different factor which may
cause leukaemia in individuals with Down's syndrome
(Fig. 1).
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nisms (T- and B-cell systems) may be inadequate to pre-
vent malignancy. On the other hand, whether it is a
transient or a permanent phenomenon, all children with
Down's syndrome may not exhibit the same degree of
cellular deficiency.
A high prevalence of Australian antigenaemia in indi-
viduals with Down's syndrome has been established.
Sutnick et al'" found 2 groups of patients with Down's
syndrome with greater and lesser degrees of cellular
immunodeficiency. The former may be more prone to
become persistent HBsAg carriers (and to develop leukae-
mia?). Campion and Wangel" attempted to define the
relative importance of HBsAg carrier status and cell-
mediated immune response in Down's syndrome. They
demonstrated an association, but the correlation was not
complete and it was thought unlikely that defective cell-
mediated immunity could be the only reason for the
HBsAg carrier state. Geographical factors, age and the
size of the institution seem to influence the prevalence of
HBsAg among groups of people with Down's syndrome.
An increased prevalence of antithyroid" and smooth
muscle auto-antibodies" has been found in the serum of
individuals with Down's syndrome. According to Schaller"
one could postulate that viruses play a major role in the
aetiology and pathogenesis of human auto-immune
diseases. Viruses appear to be capable of exerting signifi-
cant effects on the host immune system, including depres-
sion of T-cell function and stimulation of B-cell function.
Individuals with some underlying immune deficiency might
be predisposed to harbour the viruses in the first place.
This concept appears to fit in very well with what is known
about auto-antibodies, depressed T-cell function and anti-
viral immunodeficiency in Down's syndrome.
CANCER RISK IN DOWN'S SYNDROME Fig. 1. Proposed multifactorial concept of leukaemo-genesis in Down's syndrome.
Three surveillance mechanisms seem to protect normal
individuals from cancer, according to a scheme proposed
by Kersey and Good."
Target cells must be relatively resistant to transformation
by exogenous or endogenous agents. The increased suscepti-
bility to oncogenic SV40 virus transformation indicates an
intracellular or first-component defect in patients with
Down's syndrome.
Both cellular and humoral mediated immune responses
are important in the subsequent control of a transformed
cell. In addition to the deficiency of T cells, which has
been mentioned, B-cell defects also exist in Down's syn-
drome. These second-component defects would allow
uncontrolled proliferation of transformed target cells.
Variation in the degree of T- and B-cell defects may partly
explain why only some children with Down's syndrome
develop leukaemia. Chronic antigenic stimulation, lack of
immunoregulatory feedback mechanisms and undefined
graft-versus-host reactions also feature in the scheme of
Kersey and Good. The significance of these factors -in
Down's syndrome is unknown.
CONCLUSIO
Present knowledge of genetics, immunology, virology,
haematology and cytology makes it possible to construct a
We wish to repeat the idea expressed by Burkitt' that
cancer research is '... sometimes too "blinkered" in that
it often tends to be focused only on malignant lesions to
the exclusion of other conditions, the investigation of which
might point the way to a better understanding of certain
forms of cancer'.
In view of the special circumstances associated with
Down's syndrome, the individuals with this condition pro-
vide a suitable model for the investigation of the complex
interaction between genetics, viruses and the environment.
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